Pharmaceutical Sector Country Profiles Experiences and Plans Dr Gilles Forte Dr Richard Laing...

Pharmaceutical Sector Country Profiles

Experiences and Plans

Dr Gilles ForteDr Gilles Forte

Dr Richard LaingDr Richard Laing

Essential Medicines and Health Products Department

WHO HQ

WHO/GF Pharmaceutical Sector Country Profiles | April 19, 20232 |

Issues to address Issues to address

A vast amount of information exists on the pharmaceutical sector of countries;

BUT this information is often not available to the public or even to decision makers in the countries involved;

Duplication of efforts with multiple data collection initiatives in the same country; not always endorsed;

This information is not always reliable.


WHO Pharmaceutical Sector Monitoring Tools WHO Pharmaceutical Sector Monitoring Tools

Level III Indicators for specific components of the pharmaceutical sector: Pricing Rational useHuman Resources Assessing regulatory capacityProcurement and Supply

Level II Core outcome/impact indicators

& household survey

CPHigh-level

informationMostly structures

and policies

High-level policy information (Country Profiles), through a global survey•Questionnaire to Ministry of Health•Indicators on structures, policies and outcomes;•Carried out every four years

Health facility and household surveys (Level II)•Surveys based on interviews•Indicators on policy outcome•Upon country request

Topic-specific studies (Level III)•More detailed indicators for monitoring and evaluating specific areas/components•Upon country request


Content of the Country Profile questionnaireContent of the Country Profile questionnaire Content of the Country Profile questionnaireContent of the Country Profile questionnaire

The questionnaire is divided into 9 chapters:– Health and Demographic data.– Health Services.– Policy Issues.– Medicines Trade and Production.– Medicines Regulation.– Medicines Financing.– Pharmaceutical Procurement and Distribution.– Selection and Rational Use.– Household data/access.


Rationale for Country Profiles Rationale for Country Profiles

Assist countries produce reliable indicators and information on structures, processes and outcomes; using existing data e.g. pricing & availability;

Support countries to establish a unique and reliable source of information for identifying gaps, carrying out policy dialogue and policy formulation;

Information available for coordination of international partners in countries;

Global survey in 193 Member States every four years; comparisons among large number of countries (156 in 2007; 130 in 2011), regions and income groups;

Systematic data collection allows comparison over time (2003,2007,2011);


2011 Survey: ensure quality of information2011 Survey: ensure quality of information2011 Survey: ensure quality of information2011 Survey: ensure quality of information

Year and source of each piece of information is recordedYear and source of each piece of information is recorded and key documents are provided and stored in the WHO Medicines Library. Fields for comments are provided to allow respondents to provide more nuanced information;

A manualmanual with instructions to fill in the questionnaire has been developed to guide data collection; English, French and Spanish;

A glossaryglossary with definitions of key items has been produced to make sure questions are interpreted consistently across countries and regions;

Names and contacts of respondents are collected and interactions with WHO are taking place for data quality checking;

Data is endorsedData is endorsed by a senior Official at the Ministry of Health as official country information and authorisation for disclosure granted;

Quality checking of information is supported by WHO at HQ and Regional Offices. This is done through:

– Checking with previous information available for the country;– Checking for consistency within the questionnaire;– Cross checking with other sources and profiles (for example, National Health Accounts);


2011 Survey: r2011 Survey: reduce burden of data collection in countries

2011 Survey: r2011 Survey: reduce burden of data collection in countries

Core and supplementary indicators defined; Mostly Yes/No questions; limited financial and human resources needed;

Questionnaires have been prefilled for 193 Member States with all information available at WHO HQ. About 50% of each questionnaire has been prefilled. Countries are asked to verify the information provided and fill in gaps; WHO support provided for quality checking;

The Country Profile is meant to be an official and unique source on pharmaceutical sector information in the country for national and international experts; It is expected that the availability of reliable information will reduce data collection initiatives in countries;

The questionnaire has been endorsed by The Global Fund to replace GF Health Products Management (PHPM) Profile. In 2011, It has been an important source of information and step for GF grant signing; Joint data collection between WHO and GF has been carried out in countries;

Discussions are ongoing to align the questionnaire with other International agencies e.g. Unicef, World Bank;


Countries involvement and WHO support Countries involvement and WHO support

The survey is coordinated by the Ministry of Health in countries and involves relevant national institutions e.g. MRA, NHA etc.;

EMP and 6 Regional Advisers are involved in the coordination of WHO support for country profiles completion and for collaboration with GF;;

At country level, WHO Medicines and Health systems experts collaborate and support the Ministry of Heath for collection of quality information, coordination with national institutions and GF representatives and for use of data for policy dialogue and formulation;

Country profiles are meant to be updated and published every four years;


Regional Office AFRO Regional Office EMRO

Regional Office EURO Regional Office WPRO

Regional Office SEARO Regional Office AMRO

WHO: 193 Member States WHO: 193 Member States 6 Regional Offices6 Regional Offices

WHO: 193 Member States WHO: 193 Member States 6 Regional Offices6 Regional Offices

(Source: http://www.who.int/about/regions/en/index.html)

WHO HQ Geneva

=Medicines Adviser

=Collaborating Centre


Country Profileshttp://www.who.int/medicines/areas/coordination/coordination_assessment/en/index1.html

Country Profileshttp://www.who.int/medicines/areas/coordination/coordination_assessment/en/index1.html


Regional, Global and Technical reportsRegional, Global and Technical reports

Africa, Europe, Western Pacific, Americas, Caribbean and Eastern Mediterranean Regions

Technical include Financing and Pricing, Selection Rational Use & ? Regulation

Global report


RESULTSRESULTS


Global ReportGlobal Report

1. Introduction2. Methods3. Health and Demographic Results4. Health Services5. Medicine Policy Issues6. Medicines Trade and Production7. Medicines Regulation8. Medicines Financing9. Pharmaceutical procurement and Distribution10. Selection and rational use of

medicines


Health expenditure as % of govt budgetHealth expenditure as % of govt budget


Table 4.1.5: Total Pharmaceutical Expenditures (2010)Table 4.1.5: Total Pharmaceutical Expenditures (2010)

Country group (number of countries)

Population Total Pharmaceutical Expenditure

Millions % Million US$ % %THE %GDPPer capita (US$)

WHO regionAfrica (43) 819 12.1% $19,464 1.7% 23.0% 1.3% $10.59 Americas (35) 923 13.6% $436,004 38.7% 19.8% 1.3% $87.30 Eastern Mediterranean (19) 573 8.4% $20,763 1.8% 20.1% 1.2% $50.31

Europe (52) 896 13.2% $331,683 29.5% 21.5% 1.6%

$308.48

South-East Asia (10) 1,783 26.2% $41,157 3.5% 33.2% 1.3% $13.05Western Pacific (27) 1,800 26.5% $276,362 24.6% 18.7% 1.2% $37.90 World Bank income group

High-income (49) 1,092 16.1% $775,305 68.9% 18.5% 1.4%

$463.59

Upper-middle-income (55) 2,474 36.4% $283,864 25.2% 21.2% 1.3% $96.78 Lower-middle-income (50) 2,480 36.5% $59,580 5.3% 23.6% 1.3% $26.28Low-income (32) 749 11.0% $6,683 0.6% 27.7% 1.6% $8.01 GlobalGlobal (186) 6,795 $1,125,433 20.8% 1.4% $68.78

Source: World Health Organization Global Health Observatory Database, 2013 National Health Accounts, 2013


Median number of pharmacists per 10,000 by WHO Region

Median number of pharmacists per 10,000 by WHO Region

N


Taxes on medicinesTaxes on medicinesVAT on Pharmaceuticals

7% 8%10% 10% 10% 10% 10%

12% 12%13%

14% 14% 15% 15% 15%

18% 18%20% 21%

0%

5%

10%

15%

20%

25%


HIV/AIDS antiretrovirals provided free at primary healthcare facilities over time by income group

HIV/AIDS antiretrovirals provided free at primary healthcare facilities over time by income group


Global,Regional and Technical ReportsGlobal,Regional and Technical Reports

Web Publications of Country Profiles and Data available at: http://www.who.int/medicines/areas/coordination/coordination_assessment/en/index1.html

Regional Reports for AFRO, EURO, WPRO produced by Regional Offices and Utrecht University CC

Global Report produced by HQ Team, University of Utrecht CC, Jonny Meldrum, Catherine Shih

Technical Reports on – Financing and pricing– Selection– Rational Use


Evaluation of 2011 PCP SurveyEvaluation of 2011 PCP Survey

Quantitative Evaluation– Data from 143 responders and 54 prefilled– Response rates over 60% for the core indicator questions

highest was Health and Demographic data, 84% and was lower for Procurement (57%), Medicines Financing (48%) and Household data (22%)

– 324 questions out of the 493 core and supplementary questions were prefilled, representing a 66% average prefill rate for the entire questionnaire.

– Of these 324 prefilled questions, 208 were changed by one or more of the respondents, representing an average change rate of 65% for the entire set of prefilled questions


Qualitative Evaluation– 37 respondents replied with follow up in depth telephone interviews

were undertaken with 7 respondents. A conference call was also made with the EMRO senior staff.

– Prefilling was recognized as being helpful and efficient in the validation and completion of the questionnaire and focussed country attention on data to be checked and/or changed.

– The length of the questionnaire was considered reasonable. – The Instruction Manual and Glossary were not always thought to be

useful in their current format– There was frequent criticism of the use of the Word based

instrument including problems with macros with strong support for the use of a web based software for the next survey.


Plans for 2015 Country Profile Activities Plans for 2015 Country Profile Activities

Evaluation of 2011 Survey Quant and Qual 3 months 2 BU interns

Meet with NPOs and Regional Advisers Sept 2013

Revise pilot questionnaire and consult Technical units Oct 2013

Generate and Prefill questionnaire Nov Dec 2013

Revise manual, glossary and questionaire

Work with RA’s and 12 Pilot countries Feb 2014

Send out March 2014 to 12 pilot countries complete by end May 2014

Clean, analyze and write 2 reports (Summary and Process) June-July 2014

Revise Global questionnaire, prefill and set up instrument Aug-Dec 2014

Send out Jan 2014 with regional and HQ support Jan-April 2015 * * * * * * *

Clean analyze and write country reports May-July 2015 * *

Write global, regional and technical reports Aug-Dec 2015 * *


Global Health ObservatoryGlobal Health Observatory










Date post:	22-Dec-2015
Category:	Documents
Upload:	preston-lyons
View:	220 times
Download:	0 times

Pharmaceutical Sector Country Profiles Experiences and Plans Dr Gilles Forte Dr Richard Laing...

Documents